Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | RORC | P51449 | 4/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6433015 | 0.91 | RXFP1 (0.46) | RXFP1HTTTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL7141582 | 0.90 | RORC (0.38) | RXFP1RORC | |
| SCHEMBL7703099 | 0.88 | RXFP1 (0.49) | RXFP1HTTTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL7143603 | 0.87 | RXFP1 (0.43) | RXFP1HTTTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL7143085 | 0.81 | GSK3B (0.38) | RXFP1ALDH1A1RORCKMT2A | |
| SCHEMBL5869052 | 0.81 | GSK3B (0.41) | ALDH1A1RORC | |
| SCHEMBL7143091 | 0.78 | RORC (0.35) | RXFP1TDP1ALDH1A1RORC | |
| SCHEMBL5868789 | 0.77 | GSK3B (0.40) | ALDH1A1RORC | |
| SCHEMBL6433579 | 0.77 | KMT2A (0.39) | ALDH1A1RORCKMT2A | |
| SCHEMBL14753361 | 0.77 | GSK3B (0.44) | SMN1; SMN2RORCNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224174-B1 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2003-09-17 | — | — | EP | disclosed |
| US-6407094-B1 | 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA | HOFFMANN-LA ROCHE INC. | 2002-06-18 | — | — | US | disclosed |